-
Je něco špatně v tomto záznamu ?
Human cytochrome-P450 enzymes metabolize N-(2-methoxyphenyl)hydroxylamine, a metabolite of the carcinogens o-anisidine and o-nitroanisole, thereby dictating its genotoxicity
K. Naiman, M. Martínková, HH. Schmeiser, E. Frei, M. Stiborová,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články
- MeSH
- adukty DNA metabolismus MeSH
- aniliny metabolismus MeSH
- anisoly metabolismus MeSH
- hydroxylaminy metabolismus MeSH
- jaterní mikrozomy metabolismus MeSH
- karcinogeny metabolismus MeSH
- krysa rodu rattus MeSH
- látky znečišťující životní prostředí metabolismus MeSH
- lidé MeSH
- potkani Wistar MeSH
- systém (enzymů) cytochromů P-450 metabolismus MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- lidé MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
N-(2-Methoxyphenyl)hydroxylamine is a component in the human metabolism of two industrial and environmental pollutants and bladder carcinogens, viz. 2-methoxyaniline (o-anisidine) and 2-methoxynitrobenzene (o-nitroanisole), and it is responsible for their genotoxicity. Besides its capability to form three deoxyguanosine adducts in DNA, N-(2-methoxyphenyl)-hydroxylamine is also further metabolized by hepatic microsomal enzymes. To investigate its metabolism by human hepatic microsomes and to identify the major microsomal enzymes involved in this process are the aims of this study. N-(2-Methoxyphenyl)hydroxylamine is metabolized by human hepatic microsomes predominantly to o-anisidine, one of the parent carcinogens from which N-(2-methoxyphenyl)hydroxylamine is formed, while o-aminophenol and two N-(2-methoxyphenyl)hydroxylamine metabolites, whose exact structures have not been identified as yet, are minor products. Selective inhibitors of microsomal CYPs, NADPH:CYP reductase and NADH:cytochrome-b(5) reductase were used to characterize human liver microsomal enzymes reducing N-(2-methoxyphenyl)hydroxylamine to o-anisidine. Based on these studies, we attribute the main activity for this metabolic step in human liver to CYP3A4, 2E1 and 2C (more than 90%). The enzymes CYP2D6 and 2A6 also partake in this N-(2-methoxyphenyl)hydroxylamine metabolism in human liver, but only to ∼6%. Among the human recombinant CYP enzymes tested in this study, human CYP2E1, followed by CYP3A4, 1A2, 2B6 and 2D6, were the most efficient enzymes metabolizing N-(2-methoxyphenyl)hydroxylamine to o-anisidine. The results found in this study indicate that genotoxicity of N-(2-methoxyphenyl)hydroxylamine is dictated by its spontaneous decomposition to nitrenium/carbenium ions generating DNA adducts, and by its susceptibility to metabolism by CYP enzymes.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12022490
- 003
- CZ-PrNML
- 005
- 20120918112132.0
- 007
- ta
- 008
- 120806e20110918ne f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.mrgentox.2011.09.010 $2 doi
- 035 __
- $a (PubMed)21946300
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Naiman, Karel $u Department of Biochemistry, Charles University, Prague, Czech Republic.
- 245 10
- $a Human cytochrome-P450 enzymes metabolize N-(2-methoxyphenyl)hydroxylamine, a metabolite of the carcinogens o-anisidine and o-nitroanisole, thereby dictating its genotoxicity / $c K. Naiman, M. Martínková, HH. Schmeiser, E. Frei, M. Stiborová,
- 520 9_
- $a N-(2-Methoxyphenyl)hydroxylamine is a component in the human metabolism of two industrial and environmental pollutants and bladder carcinogens, viz. 2-methoxyaniline (o-anisidine) and 2-methoxynitrobenzene (o-nitroanisole), and it is responsible for their genotoxicity. Besides its capability to form three deoxyguanosine adducts in DNA, N-(2-methoxyphenyl)-hydroxylamine is also further metabolized by hepatic microsomal enzymes. To investigate its metabolism by human hepatic microsomes and to identify the major microsomal enzymes involved in this process are the aims of this study. N-(2-Methoxyphenyl)hydroxylamine is metabolized by human hepatic microsomes predominantly to o-anisidine, one of the parent carcinogens from which N-(2-methoxyphenyl)hydroxylamine is formed, while o-aminophenol and two N-(2-methoxyphenyl)hydroxylamine metabolites, whose exact structures have not been identified as yet, are minor products. Selective inhibitors of microsomal CYPs, NADPH:CYP reductase and NADH:cytochrome-b(5) reductase were used to characterize human liver microsomal enzymes reducing N-(2-methoxyphenyl)hydroxylamine to o-anisidine. Based on these studies, we attribute the main activity for this metabolic step in human liver to CYP3A4, 2E1 and 2C (more than 90%). The enzymes CYP2D6 and 2A6 also partake in this N-(2-methoxyphenyl)hydroxylamine metabolism in human liver, but only to ∼6%. Among the human recombinant CYP enzymes tested in this study, human CYP2E1, followed by CYP3A4, 1A2, 2B6 and 2D6, were the most efficient enzymes metabolizing N-(2-methoxyphenyl)hydroxylamine to o-anisidine. The results found in this study indicate that genotoxicity of N-(2-methoxyphenyl)hydroxylamine is dictated by its spontaneous decomposition to nitrenium/carbenium ions generating DNA adducts, and by its susceptibility to metabolism by CYP enzymes.
- 650 _2
- $a aniliny $x metabolismus $7 D000814
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a anisoly $x metabolismus $7 D000840
- 650 _2
- $a karcinogeny $x metabolismus $7 D002273
- 650 _2
- $a systém (enzymů) cytochromů P-450 $x metabolismus $7 D003577
- 650 _2
- $a adukty DNA $x metabolismus $7 D018736
- 650 _2
- $a látky znečišťující životní prostředí $x metabolismus $7 D004785
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hydroxylaminy $x metabolismus $7 D006898
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a jaterní mikrozomy $x metabolismus $7 D008862
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Martínková, Markéta
- 700 1_
- $a Schmeiser, Heinz H
- 700 1_
- $a Frei, Eva
- 700 1_
- $a Stiborová, Marie
- 773 0_
- $w MED00003430 $t Mutation research $x 0027-5107 $g Roč. 726, č. 2 (20110918), s. 160-8
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/21946300 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120806 $b ABA008
- 991 __
- $a 20120918112313 $b ABA008
- 999 __
- $a ok $b bmc $g 944403 $s 779787
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2011 $b 726 $c 2 $d 160-8 $e 20110918 $i 0027-5107 $m Mutation research $n Mutat Res $x MED00003430
- LZP __
- $a Pubmed-20120806/12/01